Tapewire

NYSE · USD

HPQ

HP INC

Export transactions ↓
Tapewire entity
642
SEC CIK
0000047217
Parsed reports
606

Last 12 months

Inside the activity.

0 purchase rows · 10 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202503
Jan 202600
Feb 202600
Mar 202601
Apr 202600
May 202600
Jun 202601
Jul 202601
Aug 202603
Sep 202600
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
April 24, 2023 Filed Apr 26, 2023 21:13 UTC
SURESH SUBRADirector
GrantCommon Stock 7,466 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-025719 · doc4.xml · nonDerivative · entry 1

SURESH SUBRA · CIK 0001658316 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,132

F1 · shares: On April 24, 2023, the reporting person was granted 7,466 restricted stock units, all of which vested on the grant date.

Read SEC document
April 24, 2023 Filed Apr 26, 2023 21:13 UTC GrantRestricted Stock Units · Derivative 7,466 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-025718 · doc4.xml · derivative · entry 1

Rucker Kim K.W. · CIK 0001430329 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,466

Underlying: Common Stock · 7,466 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock.

F2 · shares: On April 24, 2023, the reporting person was granted 7,466 RSUs, all of which vested on the grant date.

F2 · price: On April 24, 2023, the reporting person was granted 7,466 RSUs, all of which vested on the grant date.

F2 · derivative.exercise_date: On April 24, 2023, the reporting person was granted 7,466 RSUs, all of which vested on the grant date.

F3 · derivative.exercise_date: The reporting person elected to defer the receipt of common stock until the termination of her service as a member of HP's Board of Directors.

F2 · derivative.expiration_date: On April 24, 2023, the reporting person was granted 7,466 RSUs, all of which vested on the grant date.

Read SEC document
April 24, 2023 Filed Apr 26, 2023 21:12 UTC GrantCommon Stock 7,466 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-025717 · doc4.xml · nonDerivative · entry 1

Miscik Judith A · CIK 0001555318 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,407

F1 · shares: On April 24, 2023, the reporting person was granted 7,466 restricted stock units, all of which vested on the grant date.

Read SEC document
April 24, 2023 Filed Apr 26, 2023 21:12 UTC GrantRestricted Stock Units · Derivative 3,563 $29.47 $105,001.61
Disclosure

SEC source: 0001209191-23-025716 · doc4.xml · derivative · entry 2

CLEMMER RICHARD L · CIK 0001222781 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,563

Underlying: Common Stock · 3,563 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock.

F4 · shares: On April 24, 2023, the reporting person was granted 3,563 RSUs, all of which vested on the grant date. These RSUs were issued to the reporting person in lieu of the annual director cash retainer.

F4 · price: On April 24, 2023, the reporting person was granted 3,563 RSUs, all of which vested on the grant date. These RSUs were issued to the reporting person in lieu of the annual director cash retainer.

F3 · derivative.exercise_date: The reporting person elected to defer the receipt of common stock until the termination of his service as a member of HP's Board of Directors.

F4 · derivative.exercise_date: On April 24, 2023, the reporting person was granted 3,563 RSUs, all of which vested on the grant date. These RSUs were issued to the reporting person in lieu of the annual director cash retainer.

F4 · derivative.expiration_date: On April 24, 2023, the reporting person was granted 3,563 RSUs, all of which vested on the grant date. These RSUs were issued to the reporting person in lieu of the annual director cash retainer.

Read SEC document
April 24, 2023 Filed Apr 26, 2023 21:12 UTC GrantRestricted Stock Units · Derivative 7,466 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-025716 · doc4.xml · derivative · entry 1

CLEMMER RICHARD L · CIK 0001222781 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,466

Underlying: Common Stock · 7,466 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock.

F2 · shares: On April 24, 2023, the reporting person was granted 7,466 RSUs, all of which vested on the grant date.

F2 · price: On April 24, 2023, the reporting person was granted 7,466 RSUs, all of which vested on the grant date.

F2 · derivative.exercise_date: On April 24, 2023, the reporting person was granted 7,466 RSUs, all of which vested on the grant date.

F3 · derivative.exercise_date: The reporting person elected to defer the receipt of common stock until the termination of his service as a member of HP's Board of Directors.

F2 · derivative.expiration_date: On April 24, 2023, the reporting person was granted 7,466 RSUs, all of which vested on the grant date.

Read SEC document
April 24, 2023 Filed Apr 26, 2023 21:11 UTC GrantRestricted Stock Units · Derivative 3,563 $29.47 $105,001.61
Disclosure

SEC source: 0001209191-23-025715 · doc4.xml · derivative · entry 2

Citrino Mary Anne · CIK 0001334494 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,563

Underlying: Common Stock · 3,563 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock.

F4 · shares: On April 24, 2023, the reporting person was granted 3,563 RSUs, all of which vested on the grant date. These RSUs were issued to the reporting person in lieu of the annual director cash retainer.

F4 · price: On April 24, 2023, the reporting person was granted 3,563 RSUs, all of which vested on the grant date. These RSUs were issued to the reporting person in lieu of the annual director cash retainer.

F3 · derivative.exercise_date: The reporting person elected to defer the receipt of common stock until the termination of her service as a member of HP's Board of Directors.

F4 · derivative.exercise_date: On April 24, 2023, the reporting person was granted 3,563 RSUs, all of which vested on the grant date. These RSUs were issued to the reporting person in lieu of the annual director cash retainer.

F4 · derivative.expiration_date: On April 24, 2023, the reporting person was granted 3,563 RSUs, all of which vested on the grant date. These RSUs were issued to the reporting person in lieu of the annual director cash retainer.

Read SEC document
April 24, 2023 Filed Apr 26, 2023 21:11 UTC GrantRestricted Stock Units · Derivative 7,466 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-025715 · doc4.xml · derivative · entry 1

Citrino Mary Anne · CIK 0001334494 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,466

Underlying: Common Stock · 7,466 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock.

F2 · shares: On April 24, 2023, the reporting person was granted 7,466 RSUs, all of which vested on the grant date.

F2 · price: On April 24, 2023, the reporting person was granted 7,466 RSUs, all of which vested on the grant date.

F2 · derivative.exercise_date: On April 24, 2023, the reporting person was granted 7,466 RSUs, all of which vested on the grant date.

F3 · derivative.exercise_date: The reporting person elected to defer the receipt of common stock until the termination of her service as a member of HP's Board of Directors.

F2 · derivative.expiration_date: On April 24, 2023, the reporting person was granted 7,466 RSUs, all of which vested on the grant date.

Read SEC document
April 24, 2023 Filed Apr 26, 2023 21:11 UTC GrantRestricted Stock Units · Derivative 7,466 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-025714 · doc4.xml · derivative · entry 1

BURNS STEPHANIE · CIK 0001257094 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,466

Underlying: Common Stock · 7,466 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock.

F2 · shares: On April 24, 2023, the reporting person was granted 7,466 RSUs, all of which vested on the grant date.

F2 · price: On April 24, 2023, the reporting person was granted 7,466 RSUs, all of which vested on the grant date.

F2 · derivative.exercise_date: On April 24, 2023, the reporting person was granted 7,466 RSUs, all of which vested on the grant date.

F3 · derivative.exercise_date: The reporting person elected to defer the receipt of common stock until the termination of her service as a member of HP's Board of Directors.

F2 · derivative.expiration_date: On April 24, 2023, the reporting person was granted 7,466 RSUs, all of which vested on the grant date.

Read SEC document
April 24, 2023 Filed Apr 26, 2023 21:11 UTC GrantRestricted Stock Units · Derivative 7,466 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-025713 · doc4.xml · derivative · entry 1

BROWN-PHILPOT STACY · CIK 0001656243 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,466

Underlying: Common Stock · 7,466 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock.

F2 · shares: On April 24, 2023, the reporting person was granted 7,466 RSUs, all of which vested on the grant date.

F2 · price: On April 24, 2023, the reporting person was granted 7,466 RSUs, all of which vested on the grant date.

F2 · derivative.exercise_date: On April 24, 2023, the reporting person was granted 7,466 RSUs, all of which vested on the grant date.

F3 · derivative.exercise_date: The reporting person elected to defer the receipt of common stock until the termination of her service as a member of HP's Board of Directors.

F2 · derivative.expiration_date: On April 24, 2023, the reporting person was granted 7,466 RSUs, all of which vested on the grant date.

Read SEC document
April 24, 2023 Filed Apr 26, 2023 21:10 UTC GrantCommon Stock 3,563 $29.47 $105,001.61
Disclosure

SEC source: 0001209191-23-025710 · doc4.xml · nonDerivative · entry 2

BROUSSARD BRUCE D · CIK 0001185643 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,739

F2 · shares: On April 24, 2023, the reporting person was granted 3,563 RSUs, all of which vested on the grant date. These RSUs were issued to the reporting person in lieu of the annual director cash retainer.

Read SEC document
April 24, 2023 Filed Apr 26, 2023 21:10 UTC GrantCommon Stock 7,466 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-025710 · doc4.xml · nonDerivative · entry 1

BROUSSARD BRUCE D · CIK 0001185643 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,176

F1 · shares: On April 24, 2023, the reporting person was granted 7,466 restricted stock units ("RSUs"), all of which vested on the grant date.

Read SEC document
April 24, 2023 Filed Apr 26, 2023 21:10 UTC GrantRestricted Stock Units · Derivative 3,563 $29.47 $105,001.61
Disclosure

SEC source: 0001209191-23-025708 · doc4.xml · derivative · entry 2

Bergh Charles V · CIK 0001436534 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,563

Underlying: Common Stock · 3,563 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock.

F4 · shares: On April 24, 2023, the reporting person was granted 3,563 RSUs, all of which vested on the grant date. These RSUs were issued to the reporting person in lieu of the annual director cash retainer.

F4 · price: On April 24, 2023, the reporting person was granted 3,563 RSUs, all of which vested on the grant date. These RSUs were issued to the reporting person in lieu of the annual director cash retainer.

F3 · derivative.exercise_date: The reporting person elected to defer the receipt of common stock until April 1, 2030.

F4 · derivative.exercise_date: On April 24, 2023, the reporting person was granted 3,563 RSUs, all of which vested on the grant date. These RSUs were issued to the reporting person in lieu of the annual director cash retainer.

F4 · derivative.expiration_date: On April 24, 2023, the reporting person was granted 3,563 RSUs, all of which vested on the grant date. These RSUs were issued to the reporting person in lieu of the annual director cash retainer.

Read SEC document
April 24, 2023 Filed Apr 26, 2023 21:10 UTC GrantRestricted Stock Units · Derivative 7,466 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-025708 · doc4.xml · derivative · entry 1

Bergh Charles V · CIK 0001436534 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,466

Underlying: Common Stock · 7,466 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock.

F2 · shares: On April 24, 2023, the reporting person was granted 7,466 RSUs, all of which vested on the grant date.

F2 · price: On April 24, 2023, the reporting person was granted 7,466 RSUs, all of which vested on the grant date.

F2 · derivative.exercise_date: On April 24, 2023, the reporting person was granted 7,466 RSUs, all of which vested on the grant date.

F3 · derivative.exercise_date: The reporting person elected to defer the receipt of common stock until April 1, 2030.

F2 · derivative.expiration_date: On April 24, 2023, the reporting person was granted 7,466 RSUs, all of which vested on the grant date.

Read SEC document
April 24, 2023 Filed Apr 26, 2023 21:09 UTC GrantRestricted Stock Units · Derivative 7,466 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-025706 · doc4.xml · derivative · entry 1

BENNETT ROBERT R · CIK 0001119603 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,466

Underlying: Common Stock · 7,466 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock.

F2 · shares: On April 24, 2023, the reporting person was granted 7,466 RSUs, all of which vested on the grant date.

F2 · price: On April 24, 2023, the reporting person was granted 7,466 RSUs, all of which vested on the grant date.

F2 · derivative.exercise_date: On April 24, 2023, the reporting person was granted 7,466 RSUs, all of which vested on the grant date.

F3 · derivative.exercise_date: The reporting person elected to defer the receipt of common stock until the termination of his service as a member of HP's Board of Directors.

F2 · derivative.expiration_date: On April 24, 2023, the reporting person was granted 7,466 RSUs, all of which vested on the grant date.

Read SEC document
April 24, 2023 Filed Apr 26, 2023 21:09 UTC GrantCommon Stock 3,563 $29.47 $105,001.61
Disclosure

SEC source: 0001209191-23-025704 · doc4.xml · nonDerivative · entry 2

Banerji Shumeet · CIK 0001511649 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,737

F2 · shares: On April 24, 2023, the reporting person was granted 3,563 RSUs, all of which vested on the grant date. These RSUs were issued to the reporting person in lieu of the annual director cash retainer.

Read SEC document
April 24, 2023 Filed Apr 26, 2023 21:09 UTC GrantCommon Stock 7,466 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-025704 · doc4.xml · nonDerivative · entry 1

Banerji Shumeet · CIK 0001511649 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,174

F1 · shares: On April 24, 2023, the reporting person was granted 7,466 restricted stock units ("RSUs"), all of which vested on the grant date.

Read SEC document
April 24, 2023 Filed Apr 26, 2023 21:09 UTC
ALVAREZ AIDADirector
GrantCommon Stock 7,466 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-025703 · doc4.xml · nonDerivative · entry 1

ALVAREZ AIDA · CIK 0001268885 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,108

F1 · shares: On April 24, 2023, the reporting person was granted 7,466 restricted stock units, all of which vested on the grant date.

Read SEC document
April 03, 2023 Filed Apr 3, 2023 22:18 UTC
MYERS MARIEChief Financial Officer
SaleCommon Stock 4,165 $29.34 $122,201.10
Disclosure

SEC source: 0001209191-23-022354 · doc4.xml · nonDerivative · entry 3

MYERS MARIE · CIK 0001656326 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 43,106

F2 · kind: The sales reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 9/19/2022.

Read SEC document
April 03, 2023 Filed Apr 3, 2023 22:17 UTC
LORES ENRIQUEDirector · President and CEO
SaleCommon Stock 38,000 $29.51 $1,121,380.00
Disclosure

SEC source: 0001209191-23-022353 · doc4.xml · nonDerivative · entry 1

LORES ENRIQUE · CIK 0001656242 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 766,268

F1 · kind: The sales reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 9/29/2022.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.27-$29.705, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
April 01, 2023 Filed Apr 4, 2023 21:02 UTC Exercise / conversionRestricted Stock Units · Derivative 10,589 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-022795 · doc4.xml · derivative · entry 2

Bergh Charles V · CIK 0001436534 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,589 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock.

F2 · shares: As previously reported, on 05/05/2016, the reporting person was granted 8,734 RSUs, all of which vested on the one year anniversary of the grant date. The reporting person elected to defer the receipt of HP common stock upon the vesting of RSUs until 04/01/2023. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 1,855 vested dividend equivalent rights.

F2 · price: As previously reported, on 05/05/2016, the reporting person was granted 8,734 RSUs, all of which vested on the one year anniversary of the grant date. The reporting person elected to defer the receipt of HP common stock upon the vesting of RSUs until 04/01/2023. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 1,855 vested dividend equivalent rights.

F2 · derivative.exercise_date: As previously reported, on 05/05/2016, the reporting person was granted 8,734 RSUs, all of which vested on the one year anniversary of the grant date. The reporting person elected to defer the receipt of HP common stock upon the vesting of RSUs until 04/01/2023. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 1,855 vested dividend equivalent rights.

F2 · derivative.expiration_date: As previously reported, on 05/05/2016, the reporting person was granted 8,734 RSUs, all of which vested on the one year anniversary of the grant date. The reporting person elected to defer the receipt of HP common stock upon the vesting of RSUs until 04/01/2023. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 1,855 vested dividend equivalent rights.

Read SEC document
April 01, 2023 Filed Apr 4, 2023 21:02 UTC Exercise / conversionCommon Stock 10,589 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-022795 · doc4.xml · nonDerivative · entry 1

Bergh Charles V · CIK 0001436534 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,685

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 30, 2023 Filed Apr 3, 2023 22:18 UTC
MYERS MARIEChief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 35,551 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-022354 · doc4.xml · derivative · entry 4

MYERS MARIE · CIK 0001656326 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 35,551 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock.

F4 · price: As previously reported, on 03/30/2020, the reporting person was granted 98,094 RSUs, 1/3 of which vest annually over 3 years on the anniversary of the grant date. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 2,853 vested dividend equivalent rights.

F4 · derivative.exercise_date: As previously reported, on 03/30/2020, the reporting person was granted 98,094 RSUs, 1/3 of which vest annually over 3 years on the anniversary of the grant date. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 2,853 vested dividend equivalent rights.

F4 · derivative.expiration_date: As previously reported, on 03/30/2020, the reporting person was granted 98,094 RSUs, 1/3 of which vest annually over 3 years on the anniversary of the grant date. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 2,853 vested dividend equivalent rights.

Read SEC document
March 30, 2023 Filed Apr 3, 2023 22:18 UTC
MYERS MARIEChief Financial Officer
Tax withholdingCommon Stock 10,928 $28.90 $315,819.20
Disclosure

SEC source: 0001209191-23-022354 · doc4.xml · nonDerivative · entry 2

MYERS MARIE · CIK 0001656326 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 47,271

F1 · shares: Shares withheld by HP to satisfy tax withholding upon vesting.

Read SEC document
March 30, 2023 Filed Apr 3, 2023 22:18 UTC
MYERS MARIEChief Financial Officer
Exercise / conversionCommon Stock 35,551 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-022354 · doc4.xml · nonDerivative · entry 1

MYERS MARIE · CIK 0001656326 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 58,199

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 01, 2023 Filed Mar 2, 2023 23:01 UTC
MYERS MARIEChief Financial Officer
SaleCommon Stock 7,380 $29.87 $220,440.60
Disclosure

SEC source: 0001209191-23-014891 · doc4.xml · nonDerivative · entry 1

MYERS MARIE · CIK 0001656326 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,648

F1 · kind: The sales reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 09/19/2022.

Read SEC document
February 17, 2023 Filed Feb 22, 2023 22:19 UTC
MYERS MARIEChief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 13,445 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-011762 · doc4.xml · derivative · entry 3

MYERS MARIE · CIK 0001656326 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,684

Underlying: Common Stock · 13,445 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock.

F3 · shares: As previously reported, on 02/17/2021, the reporting person was granted 38,052 RSUs, 1/3 of which vests annually over 3 years on the anniversary of the grant date. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 761 vested dividend equivalent rights.

F3 · price: As previously reported, on 02/17/2021, the reporting person was granted 38,052 RSUs, 1/3 of which vests annually over 3 years on the anniversary of the grant date. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 761 vested dividend equivalent rights.

F3 · derivative.exercise_date: As previously reported, on 02/17/2021, the reporting person was granted 38,052 RSUs, 1/3 of which vests annually over 3 years on the anniversary of the grant date. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 761 vested dividend equivalent rights.

F3 · derivative.expiration_date: As previously reported, on 02/17/2021, the reporting person was granted 38,052 RSUs, 1/3 of which vests annually over 3 years on the anniversary of the grant date. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 761 vested dividend equivalent rights.

Read SEC document
February 17, 2023 Filed Feb 22, 2023 22:19 UTC
MYERS MARIEChief Financial Officer
Tax withholdingCommon Stock 3,353 $30.16 $101,126.48
Disclosure

SEC source: 0001209191-23-011762 · doc4.xml · nonDerivative · entry 2

MYERS MARIE · CIK 0001656326 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,028

F1 · shares: Shares withheld by HP to satisfy tax withholding upon vesting.

Read SEC document
February 17, 2023 Filed Feb 22, 2023 22:19 UTC
MYERS MARIEChief Financial Officer
Exercise / conversionCommon Stock 13,445 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-011762 · doc4.xml · nonDerivative · entry 1

MYERS MARIE · CIK 0001656326 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,381

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 10, 2023 Filed Feb 14, 2023 22:01 UTC
McQuarrie David P.Chief Commercial Officer
Exercise / conversionRestricted Stock Units · Derivative 13,014 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-009214 · doc4.xml · derivative · entry 3

McQuarrie David P. · CIK 0001951912 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,278

Underlying: Common Stock · 13,014 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock.

F3 · shares: As previously reported, on 2/10/2021, the reporting person was granted 36,832 RSUs, 1/3 of which vest annually over 3 years on the anniversary of the grant date. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 737 vested dividend equivalent rights.

F3 · price: As previously reported, on 2/10/2021, the reporting person was granted 36,832 RSUs, 1/3 of which vest annually over 3 years on the anniversary of the grant date. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 737 vested dividend equivalent rights.

F3 · derivative.exercise_date: As previously reported, on 2/10/2021, the reporting person was granted 36,832 RSUs, 1/3 of which vest annually over 3 years on the anniversary of the grant date. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 737 vested dividend equivalent rights.

F3 · derivative.expiration_date: As previously reported, on 2/10/2021, the reporting person was granted 36,832 RSUs, 1/3 of which vest annually over 3 years on the anniversary of the grant date. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 737 vested dividend equivalent rights.

Read SEC document
February 10, 2023 Filed Feb 14, 2023 22:01 UTC
McQuarrie David P.Chief Commercial Officer
Tax withholdingCommon Stock 4,678 $29.97 $140,199.66
Disclosure

SEC source: 0001209191-23-009214 · doc4.xml · nonDerivative · entry 2

McQuarrie David P. · CIK 0001951912 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,887

F1 · shares: Shares withheld by HP to satisfy tax withholding upon vesting.

Read SEC document
February 10, 2023 Filed Feb 14, 2023 22:01 UTC
McQuarrie David P.Chief Commercial Officer
Exercise / conversionCommon Stock 13,014 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-009214 · doc4.xml · nonDerivative · entry 1

McQuarrie David P. · CIK 0001951912 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,565

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 01, 2023 Filed Feb 2, 2023 22:47 UTC
MYERS MARIEChief Financial Officer
SaleCommon Stock 7,380 $29.04 $214,315.20
Disclosure

SEC source: 0001209191-23-006314 · doc4.xml · nonDerivative · entry 1

MYERS MARIE · CIK 0001656326 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,936

F1 · kind: The sales reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 09/19/2022.

Read SEC document
January 03, 2023 Filed Jan 4, 2023 22:05 UTC
MYERS MARIEChief Financial Officer
SaleCommon Stock 7,380 $27.00 $199,260.00
Disclosure

SEC source: 0001209191-23-001080 · doc4.xml · nonDerivative · entry 1

MYERS MARIE · CIK 0001656326 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,316

F1 · kind: The sales reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 9/19/2022.

Read SEC document
January 03, 2023 Filed Jan 4, 2023 22:03 UTC
LORES ENRIQUEDirector · President and CEO
SaleCommon Stock 34,000 $27.13 $922,420.00
Disclosure

SEC source: 0001209191-23-001070 · doc4.xml · nonDerivative · entry 1

LORES ENRIQUE · CIK 0001656242 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 804,268

F1 · kind: The sales reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 6/7/2021.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.00-$27.25, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
December 28, 2022 Filed Dec 29, 2022 22:11 UTC
McQuarrie David P.Chief Commercial Officer
SaleCommon Stock 20,609 $26.64 $549,023.76
Disclosure

SEC source: 0001209191-22-062925 · doc4.xml · nonDerivative · entry 1

McQuarrie David P. · CIK 0001951912 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,551

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.630-$26.655, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
December 13, 2022 Filed Dec 14, 2022 22:15 UTC SaleCommon Stock 17,300 $29.53 $510,869.00
Disclosure

SEC source: 0001209191-22-061272 · doc4.xml · nonDerivative · entry 1

Banerji Shumeet · CIK 0001511649 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,708

Read SEC document
December 09, 2022 Filed Dec 13, 2022 01:20 UTC
Tran TuanPres Imaging Prtng & Solutions
SaleCommon Stock 54,115 $28.33 $1,533,077.95
Disclosure

SEC source: 0001209191-22-060813 · doc4.xml · nonDerivative · entry 1

Tran Tuan · CIK 0001793233 · Pres Imaging Prtng & Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,465

F1 · kind: The sales reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 9/29/2022.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.23-$28.41, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer the full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
December 09, 2022 Filed Dec 13, 2022 01:16 UTC
Faust Jonathan PGlobal Controller
SaleCommon Stock 6,028 $28.37 $171,014.36
Disclosure

SEC source: 0001209191-22-060806 · doc4.xml · nonDerivative · entry 1

Faust Jonathan P · CIK 0001921172 · Global Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,647

F1 · kind: The sales reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 9/29/2022.

Read SEC document
December 08, 2022 Filed Dec 13, 2022 01:20 UTC
Tran TuanPres Imaging Prtng & Solutions
GrantPerformance Contingent Stock Options · Derivative 192,418 Not disclosed Strike: $28.48 Not disclosed
Disclosure

SEC source: 0001209191-22-060813 · doc4.xml · derivative · entry 5

Tran Tuan · CIK 0001793233 · Pres Imaging Prtng & Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 192,418

Underlying: Common Stock · 192,418 shares

Expires 2032-12-08

F8 · shares: On 12/8/2022, the reporting person was granted 192,418 performance contingent stock options, 1/3 of which vest annually over 3 years on the anniversary of the grant date, in each case subject to the satisfaction of certain stock price performance conditions.

F8 · price: On 12/8/2022, the reporting person was granted 192,418 performance contingent stock options, 1/3 of which vest annually over 3 years on the anniversary of the grant date, in each case subject to the satisfaction of certain stock price performance conditions.

F8 · derivative.exercise_date: On 12/8/2022, the reporting person was granted 192,418 performance contingent stock options, 1/3 of which vest annually over 3 years on the anniversary of the grant date, in each case subject to the satisfaction of certain stock price performance conditions.

Read SEC document
December 08, 2022 Filed Dec 13, 2022 01:20 UTC
Tran TuanPres Imaging Prtng & Solutions
GrantPerformance Adjusted Restricted Stock Units · Derivative 54,362 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-060813 · doc4.xml · derivative · entry 4

Tran Tuan · CIK 0001793233 · Pres Imaging Prtng & Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,362

Underlying: Common Stock · 54,362 shares

Expires not disclosed

F6 · derivative.exercise_price: Each performance adjusted restricted stock unit ("PARSU") represents a contingent right to receive one share of HP common stock.

F7 · shares: On 12/8/2022, the reporting person was granted 54,362 PARSUs, which will only be earned after certification of financial results as of October 31, 2025, subject to certain earnings per share and relative total stockholder return conditions being met as of that date. Depending on the level of achievement of such goals, the actual number of PARSUs earned can range from 0% to 300% of the target number of PARSUs shown in column 5. Dividend equivalent rights accrue with respect to these PARSUs when and as dividends are paid on HP common stock.

F7 · price: On 12/8/2022, the reporting person was granted 54,362 PARSUs, which will only be earned after certification of financial results as of October 31, 2025, subject to certain earnings per share and relative total stockholder return conditions being met as of that date. Depending on the level of achievement of such goals, the actual number of PARSUs earned can range from 0% to 300% of the target number of PARSUs shown in column 5. Dividend equivalent rights accrue with respect to these PARSUs when and as dividends are paid on HP common stock.

F7 · derivative.exercise_date: On 12/8/2022, the reporting person was granted 54,362 PARSUs, which will only be earned after certification of financial results as of October 31, 2025, subject to certain earnings per share and relative total stockholder return conditions being met as of that date. Depending on the level of achievement of such goals, the actual number of PARSUs earned can range from 0% to 300% of the target number of PARSUs shown in column 5. Dividend equivalent rights accrue with respect to these PARSUs when and as dividends are paid on HP common stock.

F7 · derivative.expiration_date: On 12/8/2022, the reporting person was granted 54,362 PARSUs, which will only be earned after certification of financial results as of October 31, 2025, subject to certain earnings per share and relative total stockholder return conditions being met as of that date. Depending on the level of achievement of such goals, the actual number of PARSUs earned can range from 0% to 300% of the target number of PARSUs shown in column 5. Dividend equivalent rights accrue with respect to these PARSUs when and as dividends are paid on HP common stock.

Read SEC document
December 08, 2022 Filed Dec 13, 2022 01:20 UTC
Tran TuanPres Imaging Prtng & Solutions
GrantRestricted Stock Units · Derivative 84,972 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-060813 · doc4.xml · derivative · entry 3

Tran Tuan · CIK 0001793233 · Pres Imaging Prtng & Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,972

Underlying: Common Stock · 84,972 shares

Expires not disclosed

F4 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock.

F5 · shares: On 12/8/2022, the reporting person was granted 84,972 RSUs, 1/3 of which vest annually over 3 years on the anniversary of 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock.

F5 · price: On 12/8/2022, the reporting person was granted 84,972 RSUs, 1/3 of which vest annually over 3 years on the anniversary of 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock.

F5 · derivative.exercise_date: On 12/8/2022, the reporting person was granted 84,972 RSUs, 1/3 of which vest annually over 3 years on the anniversary of 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock.

F5 · derivative.expiration_date: On 12/8/2022, the reporting person was granted 84,972 RSUs, 1/3 of which vest annually over 3 years on the anniversary of 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock.

Read SEC document
December 08, 2022 Filed Dec 13, 2022 01:19 UTC
MYERS MARIEChief Financial Officer
GrantPerformance Contingent Stock Options · Derivative 190,828 Not disclosed Strike: $28.48 Not disclosed
Disclosure

SEC source: 0001209191-22-060812 · doc4.xml · derivative · entry 3

MYERS MARIE · CIK 0001656326 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 190,828

Underlying: Common Stock · 190,828 shares

Expires 2032-12-08

F5 · shares: On 12/8/2022, the reporting person was granted 190,828 performance contingent stock options, 1/3 of which vest annually over 3 years on the anniversary of the grant date, in each case subject to the satisfaction of certain stock price performance conditions.

F5 · price: On 12/8/2022, the reporting person was granted 190,828 performance contingent stock options, 1/3 of which vest annually over 3 years on the anniversary of the grant date, in each case subject to the satisfaction of certain stock price performance conditions.

F5 · derivative.exercise_date: On 12/8/2022, the reporting person was granted 190,828 performance contingent stock options, 1/3 of which vest annually over 3 years on the anniversary of the grant date, in each case subject to the satisfaction of certain stock price performance conditions.

Read SEC document
December 08, 2022 Filed Dec 13, 2022 01:19 UTC
MYERS MARIEChief Financial Officer
GrantPerformance Adjusted Restricted Stock Units · Derivative 53,913 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-060812 · doc4.xml · derivative · entry 2

MYERS MARIE · CIK 0001656326 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,913

Underlying: Common Stock · 53,913 shares

Expires not disclosed

F3 · derivative.exercise_price: Each performance adjusted restricted stock unit ("PARSU") represents a contingent right to receive one share of HP common stock.

F4 · shares: On 12/8/2022, the reporting person was granted 53,913 PARSUs, which will only be earned after certification of financial results as of October 31, 2025, subject to certain earnings per share and relative total stockholder return conditions being met as of that date. Depending on the level of achievement of such goals, the actual number of PARSUs earned can range from 0% to 300% of the target number of PARSUs shown in column 5. Dividend equivalent rights accrue with respect to these PARSUs when and as dividends are paid on HP common stock.

F4 · price: On 12/8/2022, the reporting person was granted 53,913 PARSUs, which will only be earned after certification of financial results as of October 31, 2025, subject to certain earnings per share and relative total stockholder return conditions being met as of that date. Depending on the level of achievement of such goals, the actual number of PARSUs earned can range from 0% to 300% of the target number of PARSUs shown in column 5. Dividend equivalent rights accrue with respect to these PARSUs when and as dividends are paid on HP common stock.

F4 · derivative.exercise_date: On 12/8/2022, the reporting person was granted 53,913 PARSUs, which will only be earned after certification of financial results as of October 31, 2025, subject to certain earnings per share and relative total stockholder return conditions being met as of that date. Depending on the level of achievement of such goals, the actual number of PARSUs earned can range from 0% to 300% of the target number of PARSUs shown in column 5. Dividend equivalent rights accrue with respect to these PARSUs when and as dividends are paid on HP common stock.

F4 · derivative.expiration_date: On 12/8/2022, the reporting person was granted 53,913 PARSUs, which will only be earned after certification of financial results as of October 31, 2025, subject to certain earnings per share and relative total stockholder return conditions being met as of that date. Depending on the level of achievement of such goals, the actual number of PARSUs earned can range from 0% to 300% of the target number of PARSUs shown in column 5. Dividend equivalent rights accrue with respect to these PARSUs when and as dividends are paid on HP common stock.

Read SEC document
December 08, 2022 Filed Dec 13, 2022 01:19 UTC
MYERS MARIEChief Financial Officer
GrantRestricted Stock Units · Derivative 84,270 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-060812 · doc4.xml · derivative · entry 1

MYERS MARIE · CIK 0001656326 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,270

Underlying: Common Stock · 84,270 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock.

F2 · shares: On 12/8/2022, the reporting person was granted 84,270 RSUs, 1/3 of which vest annually over 3 years on the anniversary of 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock.

F2 · price: On 12/8/2022, the reporting person was granted 84,270 RSUs, 1/3 of which vest annually over 3 years on the anniversary of 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock.

F2 · derivative.exercise_date: On 12/8/2022, the reporting person was granted 84,270 RSUs, 1/3 of which vest annually over 3 years on the anniversary of 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock.

F2 · derivative.expiration_date: On 12/8/2022, the reporting person was granted 84,270 RSUs, 1/3 of which vest annually over 3 years on the anniversary of 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock.

Read SEC document
December 08, 2022 Filed Dec 13, 2022 01:18 UTC
McQuarrie David P.Chief Commercial Officer
GrantPerformance Contingent Stock Options · Derivative 117,677 Not disclosed Strike: $28.48 Not disclosed
Disclosure

SEC source: 0001209191-22-060811 · doc4.xml · derivative · entry 3

McQuarrie David P. · CIK 0001951912 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 117,677

Underlying: Common Stock · 117,677 shares

Expires 2032-12-08

F5 · shares: On 12/8/2022, the reporting person was granted 117,677 performance contingent stock options, 1/3 of which vest annually over 3 years on the anniversary of the grant date, in each case subject to the satisfaction of certain stock price performance conditions.

F5 · price: On 12/8/2022, the reporting person was granted 117,677 performance contingent stock options, 1/3 of which vest annually over 3 years on the anniversary of the grant date, in each case subject to the satisfaction of certain stock price performance conditions.

F5 · derivative.exercise_date: On 12/8/2022, the reporting person was granted 117,677 performance contingent stock options, 1/3 of which vest annually over 3 years on the anniversary of the grant date, in each case subject to the satisfaction of certain stock price performance conditions.

Read SEC document
December 08, 2022 Filed Dec 13, 2022 01:18 UTC
McQuarrie David P.Chief Commercial Officer
GrantPerformance Adjusted Restricted Stock Units · Derivative 33,246 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-060811 · doc4.xml · derivative · entry 2

McQuarrie David P. · CIK 0001951912 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,246

Underlying: Common Stock · 33,246 shares

Expires not disclosed

F3 · derivative.exercise_price: Each performance adjusted restricted stock unit ("PARSU") represents a contingent right to receive one share of HP common stock.

F4 · shares: On 12/8/2022, the reporting person was granted 33,246 PARSUs, which will only be earned after certification of financial results as of October 31, 2025, subject to certain earnings per share and relative total stockholder return conditions being met as of that date. Depending on the level of achievement of such goals, the actual number of PARSUs earned can range from 0% to 300% of the target number of PARSUs shown in column 5. Dividend equivalent rights accrue with respect to these PARSUs when and as dividends are paid on HP common stock.

F4 · price: On 12/8/2022, the reporting person was granted 33,246 PARSUs, which will only be earned after certification of financial results as of October 31, 2025, subject to certain earnings per share and relative total stockholder return conditions being met as of that date. Depending on the level of achievement of such goals, the actual number of PARSUs earned can range from 0% to 300% of the target number of PARSUs shown in column 5. Dividend equivalent rights accrue with respect to these PARSUs when and as dividends are paid on HP common stock.

F4 · derivative.exercise_date: On 12/8/2022, the reporting person was granted 33,246 PARSUs, which will only be earned after certification of financial results as of October 31, 2025, subject to certain earnings per share and relative total stockholder return conditions being met as of that date. Depending on the level of achievement of such goals, the actual number of PARSUs earned can range from 0% to 300% of the target number of PARSUs shown in column 5. Dividend equivalent rights accrue with respect to these PARSUs when and as dividends are paid on HP common stock.

F4 · derivative.expiration_date: On 12/8/2022, the reporting person was granted 33,246 PARSUs, which will only be earned after certification of financial results as of October 31, 2025, subject to certain earnings per share and relative total stockholder return conditions being met as of that date. Depending on the level of achievement of such goals, the actual number of PARSUs earned can range from 0% to 300% of the target number of PARSUs shown in column 5. Dividend equivalent rights accrue with respect to these PARSUs when and as dividends are paid on HP common stock.

Read SEC document
December 08, 2022 Filed Dec 13, 2022 01:18 UTC
McQuarrie David P.Chief Commercial Officer
GrantRestricted Stock Units · Derivative 51,966 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-060811 · doc4.xml · derivative · entry 1

McQuarrie David P. · CIK 0001951912 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,966

Underlying: Common Stock · 51,966 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock.

F2 · shares: On 12/8/2022, the reporting person was granted 51,966 RSUs, 1/3 of which vest annually over 3 years on the anniversary of 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock.

F2 · price: On 12/8/2022, the reporting person was granted 51,966 RSUs, 1/3 of which vest annually over 3 years on the anniversary of 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock.

F2 · derivative.exercise_date: On 12/8/2022, the reporting person was granted 51,966 RSUs, 1/3 of which vest annually over 3 years on the anniversary of 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock.

F2 · derivative.expiration_date: On 12/8/2022, the reporting person was granted 51,966 RSUs, 1/3 of which vest annually over 3 years on the anniversary of 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock.

Read SEC document
December 08, 2022 Filed Dec 13, 2022 01:18 UTC
Ludgate Kristen MChief People Officer
GrantPerformance Contingent Stock Options · Derivative 106,864 Not disclosed Strike: $28.48 Not disclosed
Disclosure

SEC source: 0001209191-22-060810 · doc4.xml · derivative · entry 3

Ludgate Kristen M · CIK 0001727434 · Chief People Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 106,864

Underlying: Common Stock · 106,864 shares

Expires 2032-12-08

F5 · shares: On 12/8/2022, the reporting person was granted 106,864 performance contingent stock options, 1/3 of which vest annually over 3 years on the anniversary of the grant date, in each case subject to the satisfaction of certain stock price performance conditions.

F5 · price: On 12/8/2022, the reporting person was granted 106,864 performance contingent stock options, 1/3 of which vest annually over 3 years on the anniversary of the grant date, in each case subject to the satisfaction of certain stock price performance conditions.

F5 · derivative.exercise_date: On 12/8/2022, the reporting person was granted 106,864 performance contingent stock options, 1/3 of which vest annually over 3 years on the anniversary of the grant date, in each case subject to the satisfaction of certain stock price performance conditions.

Read SEC document
December 08, 2022 Filed Dec 13, 2022 01:18 UTC
Ludgate Kristen MChief People Officer
GrantPerformance Adjusted Restricted Stock Units · Derivative 30,191 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-060810 · doc4.xml · derivative · entry 2

Ludgate Kristen M · CIK 0001727434 · Chief People Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,191

Underlying: Common Stock · 30,191 shares

Expires not disclosed

F3 · derivative.exercise_price: Each performance adjusted restricted stock unit ("PARSU") represents a contingent right to receive one share of HP common stock.

F4 · shares: On 12/8/2022, the reporting person was granted 30,191 PARSUs, which will only be earned after certification of financial results as of October 31, 2025, subject to certain earnings per share and relative total stockholder return conditions being met as of that date. Depending on the level of achievement of such goals, the actual number of PARSUs earned can range from 0% to 300% of the target number of PARSUs shown in column 5. Dividend equivalent rights accrue with respect to these PARSUs when and as dividends are paid on HP common stock.

F4 · price: On 12/8/2022, the reporting person was granted 30,191 PARSUs, which will only be earned after certification of financial results as of October 31, 2025, subject to certain earnings per share and relative total stockholder return conditions being met as of that date. Depending on the level of achievement of such goals, the actual number of PARSUs earned can range from 0% to 300% of the target number of PARSUs shown in column 5. Dividend equivalent rights accrue with respect to these PARSUs when and as dividends are paid on HP common stock.

F4 · derivative.exercise_date: On 12/8/2022, the reporting person was granted 30,191 PARSUs, which will only be earned after certification of financial results as of October 31, 2025, subject to certain earnings per share and relative total stockholder return conditions being met as of that date. Depending on the level of achievement of such goals, the actual number of PARSUs earned can range from 0% to 300% of the target number of PARSUs shown in column 5. Dividend equivalent rights accrue with respect to these PARSUs when and as dividends are paid on HP common stock.

F4 · derivative.expiration_date: On 12/8/2022, the reporting person was granted 30,191 PARSUs, which will only be earned after certification of financial results as of October 31, 2025, subject to certain earnings per share and relative total stockholder return conditions being met as of that date. Depending on the level of achievement of such goals, the actual number of PARSUs earned can range from 0% to 300% of the target number of PARSUs shown in column 5. Dividend equivalent rights accrue with respect to these PARSUs when and as dividends are paid on HP common stock.

Read SEC document
December 08, 2022 Filed Dec 13, 2022 01:18 UTC
Ludgate Kristen MChief People Officer
GrantRestricted Stock Units · Derivative 47,191 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-060810 · doc4.xml · derivative · entry 1

Ludgate Kristen M · CIK 0001727434 · Chief People Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,191

Underlying: Common Stock · 47,191 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock.

F2 · shares: On 12/8/2022, the reporting person was granted 47,191 RSUs, 1/3 of which vest annually over 3 years on the anniversary of 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock.

F2 · price: On 12/8/2022, the reporting person was granted 47,191 RSUs, 1/3 of which vest annually over 3 years on the anniversary of 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock.

F2 · derivative.exercise_date: On 12/8/2022, the reporting person was granted 47,191 RSUs, 1/3 of which vest annually over 3 years on the anniversary of 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock.

F2 · derivative.expiration_date: On 12/8/2022, the reporting person was granted 47,191 RSUs, 1/3 of which vest annually over 3 years on the anniversary of 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.